|
WO2020230810A1
|
|
Carbon quantum dots and production method for carbon quantum dots
|
|
WO2020071085A1
|
|
Superelastic material and use of same
|
|
JP2020204714A
|
|
Phantom for bone marrow puncture training and puncture stress detecting device using phantom
|
|
JP2020200264A
|
|
Monoclonal antibodies that specifically recognize activated irf5
|
|
JP2020152645A
|
|
Anti-arteriosclerosis agent
|
|
JP2020141567A
|
|
Medium for inducing spermatogenesis
|
|
JP2019131540A
|
|
Novel compound having auxin biosynthesis inhibitory activity, manufacturing method therefor and application thereof
|
|
JP2020101381A
|
|
Combined uroflowmeter
|
|
JP2020061955A
|
|
Method for detecting neonatal to childhood-onset cerebral small blood vessel disease or carriers thereof
|
|
JP2019216622A
|
|
Medium for in vitro sperm formation induction
|
|
JP2018128451A
|
|
Utilization of sugar chain structure of disease-specific tissue factor pathway inhibitor 2
|
|
JP2019023790A
|
|
Death prediction device and death prediction program
|
|
JP2017201978A
|
|
Heterologous end-linked defective cell and use thereof
|
|
JP2018111682A
|
|
Imaging method, program, and screening method for intracerebral ampa receptors of primate
|
|
JP2018145151A
|
|
Multifunctional type peptide probe, and selective concentration method of target molecule using the same
|
|
JP2017145246A
|
|
Antibody against mers coronavirus, method for detecting mers coronavirus using the antibody, and kit containing the antibody
|
|
JP2020045285A
|
|
Prophylactic and/or therapeutic agent for diseases associated with ampa receptors
|
|
JP2018088882A
|
|
Detection method of nemaline myopathy or carrier thereof
|
|
JP2018054537A
|
|
Method of providing information for predicting the prognosis of ovarian clear cell adenocarcinoma patient
|
|
JP2018042511A
|
|
Method for detecting serious childhood early-onset neurodegenerative encephalopathy or carrier thereof
|
